Arrival of Manoj Tulsiani comes as Latham says global practice is 'busier than ever' | 4yrs

New York leader dubs paying partners based on seniority incompatible with growth plans | 4yrs

July legal services revenue just 2.4% down year-on-year although concerns that recovery will be patchy linger | 4yrs

Judgment in Gary Senior case also points to 'mistakes' during firm's investigation | 4yrs

International law firms are likely to stick by Hong Kong despite rule of law concerns - at least for now | 4yrs

Plans for opening of 'fully operational' Irish branch in Q2 are put back to September | 4yrs

Last white president complains of 'vitriolic reaction' over slated appearance as apartheid-era record is questioned | 4yrs

Netlaw Media postpones web seminar to review composition of speakers after 'listening to community' | 4yrs

Jesús Varela to make move to top Spanish independent a little over a year after assuming leadership role | 4yrs

Elliott Portnoy describes feelings of 'horror, disgust and sadness' as he joins senior legal figures in condemning killing | 4yrs

Grouping, which includes GC of legal recruitment firm, wins four out of five available seats in elections to ruling council | 4yrs

Dutch firm pays tribute to 'passionate and collegial' leader with a 'big heart and great ambitions' | 4yrs

Edward Lee joins Chicago giant after advising on 2019's two highest-value deals in rare partner loss for Wachtell | 4yrs

Dutch firm Houthoff offers clients 'virtual night out' with exclusive streaming of popular ballet | 4yrs

Looming decisions over associate pay and bonuses are a factor in the timing of UK law firm Coronavirus measures | 4yrs

NRF EMEA managing partner Peter Scott on his firm's bid to safeguard jobs with its flexible working scheme | 4yrs

Consultant Tony Williams advises law firm leaders to avoid knee jerk decisions and go into communication overdrive during the Covid-19 crisis | 4yrs

Linklaters, Baker McKenzie and Ropes & Gray have published the most sought-after briefings, according to Lexology | 4yrs

Pharma giant's panel review with its diversity targets could set an important trend within the GC community | 4yrs